Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in combination therapy for the treatment of cancer

Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in combination therapy for the treatment of cancer

US Patent 7320996 · Granted Jan 22, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD38 antibodies for treatment of acute myeloid leukemia2025
Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-pos2024
Combination therapies with anti-CD38 antibodies2024
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia2023
Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)2022
Combination therapies with anti-CD38 antibodies2020
Anti-CD38 antibodies for treatment of acute myeloid leukemia2020
Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-pos2020
Combination therapies for heme malignancies with anti-CD38 antibodies and surviv2020
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia2020
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia2017
Combination therapies with anti-CD38 antibodies2017